Associate Professor of Ophthalmology and Visual Sciences, University of Michigan Kellogg Eye Center
Ophthalmology
Dr. Raymond S. Douglas, MD
|
|
Give Review
Dr. Raymond S. Douglas practices Ophthalmology. He graduated from Perelman School of Medicine at the University of Pennsylvania. He received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAO)". Raymond S. Douglas is a published doctor as well. He has 76 publications published. The latest was: Novel approach for simultaneous evaluation of cell phenotype, apoptosis, and cell cycle using multiparameter flow cytometry. He accepts all Medicare patients.
Publications
- Eyelid swelling and proPtosis with systemic implications.
- Compressive Optic Neuropathy and Repeat Orbital Decompression: A Case Series.
- Risk Factors for Developing Thyroid-Associated Ophthalmopathy Among Individuals With Graves Disease.
- Thyrotropin Receptor and CD40 Mediate Interleukin-8 Expression in Fibrocytes: Implications for Thyroid-Associated Ophthalmopathy (An American Ophthalmological Society ...
- Ocular Surface, Fornix, and Eyelid Rehabilitation in Boston Type I Keratoprosthesis Patients With Mucous Membrane Disease.
- The pathophysiology of thyroid eye disease.
- Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes.
- Rituximab (Rituxan®) therapy for severe thyroid associated ophthalmopathy diminishes IGF-1R(+) T cells.
- Interleukin-6 (IL-6) proDuction in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: Involvement of Akt and NF-κB.
- Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.
- Human fibrocytes coexpress thyroglobulin and thyrotropin receptor.
- Histopathology of Brow Fat in Thyroid-Associated Orbitopathy.
- Reliability of estimating Ductions in thyroid eye disease an international thyroid eye disease society multicenter study.
- Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.
- Pharmacotherapy: Does selenium supplementation improve Graves ophthalmopathy?
- Island Pedicle and Horizontal Advancement Cheek Flaps for Medial Canthal Reconstruction.
- The pathophysiology of thyroid eye disease: implications for immunotherapy.
- Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA.
- "En-glove" lysis of lower eyelid retractors with AlloDerm and dermis-fat grafts in lower eyelid Retraction surgery.
- Immunopathogenesis of thyroid eye disease: emerging paradigms.
- Aesthetic lateral canthoplasty.
- Endoscopic removal of nasoglabellar dermoid cysts.
- PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy.
- Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy.
- Increased generation of fibrocytes in thyroid-associated ophthalmopathy.
- Rare dural arteriovenous fistula of the lesser sphenoid wing sinus.
- Nonsurgical management of congenital Eyelid malpositions using hyaluronic Acid gel.
- Divergent frequencies of IGF-I receptor-expressing blood lymphocytes in monozygotic twin pairs discordant for Graves' disease: evidence for a phenotypic signature ascr...
- Orbital wall fracture repair using Seprafilm.
- Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.
- Use of hyaluronic Acid gel in the management of paralytic lagophthalmos: the hyaluronic Acid gel "gold weight".
- B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.
- Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.
- Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.
- A symposium on thyroid-associated ophthalmopathy, also known as Graves' orbitopathy at the Jules Stein Eye Institute at the University of California, Los Angeles.
- Biologic therapeutics in thyroid-associated ophthalmopathy: translating disease mechanism into therapy.
- The hydrogel lacrimal stent for dacryocystorhinostomy: preliminary experience.
- Congenital lacrimal sac fistula: intraoperative visualization by polyvinyl siloxane cast.
- Treatment of lower eyelid Retraction by expansion of the lower eyelid with hyaluronic Acid gel.
- Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
- Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis.
- Graves' orbitopathy.
- Comparing outcomes of enucleation and evisceration.
- Long-term efficacy of biomodeled polymethyl methacrylate implants for orbitofacial defects.
- Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 ...
- Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltra...
- Dermatofibrosarcoma protuberans metastatic to the orbit.
- Facial recontouring with autogenous fat.
- Collagen fillers in facial aesthetic surgery.
- Lumps and bumps: late postsurgical inflammatory and infectious lesions.
- Foveal spot: a report of thirteen patients.
- Encephalocraniocutaneous lipomatosis: a neurocutaneous Syndrome.
- A systematic comprehensive approach to management of irreversible facial paralysis.
- Orbital presentation of posttransplantation lymphoproliferative disorder: a small case series.
- Metastatic breast cancer to 4 Eyelids: a clinicopathologic report.
- Localized Intraorbital Castleman''s disease: a case report.
- Targeted biological therapies for Graves'' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.
- Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique.
- Reactivation of thyroid-associated orbitopathy after Cataract surgery.
- Pharmacological treatments for thyroid eye disease.
- Acute myelogenous leukaemia presenting as a Conjunctival lesion and red eye.
- Paediatric periocular granuloma annulare.
- Efficacy of "thick" acellular human dermis (AlloDerm) for lower Eyelid reconstruction: comparison with hard palate and thin AlloDerm grafts.
- Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes.
- Clinical manifestations and treatment outcome of optic neuropathy in thyroid-related orbitopathy.
- The horizontal dynamic of the medial and lateral canthus.
- Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy.
- SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells.
- Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.
- Orbital exenteration: one size does not fit all.
- Treacher Collins Syndrome with novel ophthalmic findings and visceral anomalies.
- Novel approach for simultaneous evaluation of cell phenotype, apoPtosis, and cell cycle using multiparameter flow cytometry.
- Altered response to and proDuction of TGF-beta by B cells from autoimmune NZB mice.
- A simplified method for the coordinate examination of apoPtosis and surface phenotype of murine lymphocytes.
- A three-dimensional construct of the aging eyebrow: the illusion of volume loss.
Schools
University Of Pennsylvania School Of Medicine
University Of Pennsylvania
Scheie Eye Instuniv Of Pennsylvania
Uclajules Stein Eye
Procedures Preformed
- Blepharoplasty
- Blepharorrhaphy
- Canthoplasty and Canthopexy
- Canthotomy
- View All
Conditions Treated
- Age-Related Macular Degeneration
- Anisocoria
- Bell's Palsy
- Benign Neoplasm of Eye
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAO)
Education
-
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1124041959 | |
| NPPES Provider LastName | DOUGLAS | |
| NPPES Provider FirstName | RAYMOND | |
| NPPES Provider ZIPCode | 481051912 | |
| NPPES Provider State | MI | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 23.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124041959 |
| Last Name Of The Provider | DOUGLAS |
| First Name Of The Provider | RAYMOND |
| View All |
Similar Doctors
|
|
Dr. Partho S. Kalyani, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jill E. Bixler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert I. Goldsmith, MD |
|
|
Dr. James H. Oestreicher, MD |
|
|
Dr. Sara Akbari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ariane D. Kaplan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Devon H. Ghodasra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Demill, MD |
|
|
Dr. Sherry H. Day, OD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela R. Elam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shannon J. Shan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fatemeh Rajaii, MD
This Doctor is OpenDoctor Recommended.
|